Websites linking back to pi.amgen.com

Use the Enbrel® (etanercept) site map to find the page you're looking for on Enbrel.com.

Learn about PCSK9 inhibitor Repatha®. Or get patients started with insurance verification, and financial assistance.

Find information about IMLYGIC® (talimogene laherparepvec), including details about administration, storage, safety information and more.

Learn more about preventing serious bone problems with XGEVA® (denosumab) injections.

KYPROLIS® (carfilzomib) is a treatment option for people who have already received 1 or more previous treatments for relapsed multiple myeloma. Learn how KYPROLIS may help.

Manage My Co-pay; Amgen managemycopay;

Nplate® (romiplostim) - The Official Site - Learn more about ITP (immune thrombocytopenia) and Nplate®, a treatment for adults with chronic ITP.

Repatha® (evolocumab) is used along with diet & maximally tolerated statin for high LDL cholesterol.

Learn about Neulasta® (pegfilgrastim) and Neulasta® Onpro™, the on-body injector designed to administer Neulasta®.

Learn about NEUPOGEN® (filgrastim), a daily injectable granulocyte colony-stimulating factor (GCS-F) available in two administration options.

Corlanor® (ivabradine) is a chronic heart failure treatment. Learn about Chronic HF symptoms and causes. Get the complete details on Corlanor® benefits and safety.

Learn how Prolia® (denosumab) can help in the treatment of postmenopausal osteoporosis for women at high risk for fracture.

EPOGEN® (epoetin alfa) is used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis to reduce or avoid the need for red blood cell transfusions.

Learn about clinical trial data for KYPROLIS® (carfilzomib)—treats relapsed or refractory multiple myeloma.

Enbrel® (etanercept) is a prescription medicine used to treat five chronic diseases, including moderate to severe plaque psoriasis and rheumatoid arthritis.

Learn about Vectibix® (panitumumab): an FDA-approved 1st- & 3rd-line treatment option for patients with WT RAS metastatic colorectal cancer (mCRC).